BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 3, 2000
View Archived Issues
Intensive therapy offers persistent benefits in type I diabetes
Read More
Large valsartan trial reaches enrollment objectives
Read More
Alexion makes significant progress over past six months in various development programs
Read More
Vertex enters genomic partnership with Incyte
Read More
IL-4 gene therapy studied in malignant glioma
Read More
Rebif long-term data confirm dose-related efficacy; Ares-Serono to enhance labeling
Read More
CryoLife and Viragen enter cancer therapy collaboration
Read More
Ampakine-like compounds and their use described by Lilly
Read More
Pharmachemie presents new water-soluble tin compounds with excellent antitumor activity
Read More
Guilford to develop novel propofol prodrug discovered by ProQuest
Read More
MMP inhibitors from Warner-Lambert particularly active against MMP-2, MMP-3 and MMP-13
Read More
International team provides new insight into the mechanics of HIV infection
Read More
Pharmaceutically useful neuroprotective agents emerge from R&D at Cambridge NeuroScience
Read More
ADIR's new MMP inhibitors particularly useful for cancer, rheumatoid arthritis
Read More
U.S./Russian investigators present anesthetics with useful hypometabolic, cardiovascular effects
Read More
Estrogen protects against brain damage from ischemic insult in female rats
Read More
New vitamin D4 metabolite claimed by Bone Care for vitamin D-deficient states
Read More
Schedule-dependent antitumor activity demonstrated for new modified steroidal lactams
Read More
Induction therapy with daclizumab in cardiac transplant recipients safe and effective
Read More
Actonel to be approved in Europe for Rx of postmenopausal osteoporosis
Read More
EpiGenesis and Taisho sign binding letter of intent for EPI-2010
Read More
Potent factor XIIIa inhibitor synthesized from naturally occurring cyclopropenones
Read More
Collaboration between Novartis and Emisphere extended to include second compound
Read More
Progenics announces important discoveries related to HIV fusion inhibitors
Read More
Triapine anticancer therapy completes phase I trial
Read More
Novantrone moves one step closer to approval for MS
Read More
Noven successfully completes phase II study of MethyPatch for treatment of ADHD
Read More